Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces penile erection

Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces... The effect of cannabinoid CB1 receptor agonists and antagonists on penile erection was studied in male rats when injected into the paraventricular nucleus of the hypothalamus. The CB1 receptor antagonist SR 141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide) (0.5–5 μg) induced penile erection in a dose-dependent manner. The minimal effective dose was 1 μg, while the maximal response was found with 5 μg of the compound. In contrast, the CB1 receptor agonists WIN 55,212-2 (4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo(3,2,1-I,j)quinolin-6-one) (0.5–5 μg) and CP 55,940 (1α,2β-(R)-5α)-5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxy-propyl)cyclohexyl)phenol (0.5–5 μg) were ineffective at all the doses tested. Nevertheless, both compounds reduced the enhancing effect of SR 141716A on penile erection when given into the paraventricular nucleus at the above doses before SR 141716A. The pro-erectile effect of SR 141716A was also reduced by the non-competitive NMDA receptor antagonist dizolcipine (MK-801) (0.2 μg) and by the NO synthase inhibitor NG-nitro- l -arginine methylester (L-NAME) (20 μg) but not by the dopamine receptor antagonist cis-flupenthixol (10 μg) or the oxytocin receptor antagonist d(CH 2 ) 5 Tyr(Me) 2 -Orn 8 -vasotocin (0.1 μg), when given into the paraventricular nucleus. In spite of its inability to prevent the pro-erectile effect of SR 141716A when given in the paraventricular nucleus, d(CH 2 ) 5 Tyr(Me) 2 -Orn 8 -vasotocin) (1 μg) reduced almost completely SR 141716A-induced penile erection when given into the lateral ventricles. The present results show that cannabinoid CB1 receptors present in the paraventricular nucleus may influence erectile function and sexual activity by modulating paraventricular oxytocinergic neurons mediating erectile function. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Neuroscience Letters Elsevier

Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces penile erection

Loading next page...
1
 
/lp/elsevier/antagonism-of-cannabinoid-cb1-receptors-in-the-paraventricular-nucleus-j4LrLl0CbV
Publisher
Elsevier
Copyright
Copyright © 2004 Elsevier Ireland Ltd
ISSN
0304-3940
D.O.I.
10.1016/j.neulet.2004.01.025
Publisher site
See Article on Publisher Site

Abstract

The effect of cannabinoid CB1 receptor agonists and antagonists on penile erection was studied in male rats when injected into the paraventricular nucleus of the hypothalamus. The CB1 receptor antagonist SR 141716A (N-(piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxyamide) (0.5–5 μg) induced penile erection in a dose-dependent manner. The minimal effective dose was 1 μg, while the maximal response was found with 5 μg of the compound. In contrast, the CB1 receptor agonists WIN 55,212-2 (4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo(3,2,1-I,j)quinolin-6-one) (0.5–5 μg) and CP 55,940 (1α,2β-(R)-5α)-5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxy-propyl)cyclohexyl)phenol (0.5–5 μg) were ineffective at all the doses tested. Nevertheless, both compounds reduced the enhancing effect of SR 141716A on penile erection when given into the paraventricular nucleus at the above doses before SR 141716A. The pro-erectile effect of SR 141716A was also reduced by the non-competitive NMDA receptor antagonist dizolcipine (MK-801) (0.2 μg) and by the NO synthase inhibitor NG-nitro- l -arginine methylester (L-NAME) (20 μg) but not by the dopamine receptor antagonist cis-flupenthixol (10 μg) or the oxytocin receptor antagonist d(CH 2 ) 5 Tyr(Me) 2 -Orn 8 -vasotocin (0.1 μg), when given into the paraventricular nucleus. In spite of its inability to prevent the pro-erectile effect of SR 141716A when given in the paraventricular nucleus, d(CH 2 ) 5 Tyr(Me) 2 -Orn 8 -vasotocin) (1 μg) reduced almost completely SR 141716A-induced penile erection when given into the lateral ventricles. The present results show that cannabinoid CB1 receptors present in the paraventricular nucleus may influence erectile function and sexual activity by modulating paraventricular oxytocinergic neurons mediating erectile function.

Journal

Neuroscience LettersElsevier

Published: Apr 8, 2004

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off